SIGNIA THERAPEUTICS
Signia Therapeutics proposes a breakthrough strategy to identify and repurpose rapidly, efficiently and at low cost already marketed drugs or to recycle unused drugs for new antiviral indication against several human respiratory viruses. These antiviral candidates could be directly evaluated in phase II clinical trials and/or quickly available in response to any widespread outbreak for which the medical community and patients have limited options.
SIGNIA THERAPEUTICS
Social Links:
Industry:
Medical
Founded:
2017-01-01
Address:
Villeurbanne, Rhone-Alpes, France
Country:
France
Website Url:
http://www.signiatherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(+33) 478771037
Email Addresses:
[email protected]
Total Funding:
3.07 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Healios
The UK’s leading digital healthcare company .
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Grant - Signia Therapeutics
Neovacs
Neovacs investment in Series A - Signia Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Signia Therapeutics
Official Site Inspections
http://www.signiatherapeutics.com Semrush global rank: 6.16 M Semrush visits lastest month: 1.31 K
- Host name: 172.67.176.184
- IP address: 172.67.176.184
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Signia Therapeutics"
Signia Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (+33) 478771037 Signia Therapeutics proposes a breakthrough strategy to identify and repurpose rapidly, efficiently …See details»
Signia Therapeutics SAS - Drug pipelines, Patents, Clinical trials ...
Signiatherapeutics.com. Startups | Holding Company | 2017 | France | < 10 | signiatherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Signia Therapeutics - Laboratoire VirPath - Virologie et …
Signia Therapeutics is a spin-off of the VirPath Lab (University Claude Bernard Lyon 1, Lyon, France). Signia Therapeutics proposes an innovative and versatile platform for antiviral drug …See details»
SIGNIA THERAPEUTICS Overview | SignalHire Company Profile
SIGNIA THERAPEUTICS is a research company based out of Bâtiment Adénine, 60 Avenue Rockefeller, 69008 Lyon, FranceSee details»
Company Information - RocketReach
Signiatherapeutics.com; Laetitia Lines Research Engineer at SIGNIA THERAPEUTICS Lyon, FR View. 1 signiatherapeutics.com; 2 3366895XXXX; 3347877XXXX; View Similar People. …See details»
Signia Therapeutics - VentureRadar
Website: https://signiatherapeutics.com/ Signia Therapeutics is an innovative French start-up from the VirPath laboratory of the University Claude Bernard (Lyon).See details»
SIGNIA THERAPEUTICS | LinkedIn
SIGNIA THERAPEUTICS | 915 followers on LinkedIn. Breakthrough Solution for Respiratory Infections | SIGNIA THERAPEUTICS is a research company based out of Bâtiment Adénine, …See details»
SIGNIA THERAPEUTICS - explore.openaire.eu
Organization, country, SIGNIA THERAPEUTICSSIGNIA THERAPEUTICS. SIGNIA (SIGNIA: An innovative drug discovery platform for rapid identification and validation of antimicrobial …See details»
Signia Therapeutics Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Signia Therapeutics. See Signia Therapeutics company profile and funding data.See details»
Signia Therapeutics - CoBee Company Profile & Funding Rounds
Signia Therapeutics proposes a breakthrough strategy to identify and repurpose rapidly, efficiently and at low cost already marketed drugs or to recycle unused drugs for new antiviral indication …See details»
Signia Therapeutics - Craft
Signia Therapeutics is a company developing a solution for respiratory infections. It identifies and repurposes already marketed drugs or recycles unused drugs for new antiviral indication …See details»
Company Information - RocketReach
SIGNIA THERAPEUTICS employs 7 employees. The SIGNIA THERAPEUTICS management team includes Julien Fouret (Head of Bioinformatics and Data Science), Catalina Gonzalez …See details»
Signiatherapeutics Cyber Security Rating & Vendor Risk Report ...
View Signiatherapeutics's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving SigniatherapeuticsSee details»
Signia Therapeutics SAS: 药物管线_专利_临床试验_投融营收_最新 …
了解Signia Therapeutics SAS公司的药物管线,治疗领域,技术平台,以及它的1项临床试,疾病领域:感染,技术平台:未知,药物:ST14 (Signia Therapeutics)。See details»
Philippe Personne, Président at Colca Medical & Scientific
Président (President) at Colca Medical & Scientific. See Philippe Personne's email address, phone number and work experience.See details»
Company Information - RocketReach
The most common SIGNIA THERAPEUTICS email format is [first] (ex. [email protected]), which is being used by 60.0% of SIGNIA THERAPEUTICS …See details»
Signet Therapeutics - VentureRadar
Similar Companies: Myricx Pharma United Kingdom Privately Held Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of …See details»
signiatherapeutics.com keyword research: organic and paid …
The analysis of signiatherapeutics.com can help you understand their performance in organic results and what keywords signiatherapeutics.com is using for running paid ads on Google …See details»
Home | Oniria Therapeutics
At ONIRIA Therapeutics, we translate hard-won knowledge on cancer cell resistance to advanced treatments for patients.We have found that latent cells exist from the very beginning in primary …See details»
Speranza Therapeutics | Bridging the Gap Between Hope & Healing
Introducing S.T. Genesis A noninvasive treatment to manage opioid withdrawal symptoms Our FDA-cleared Percutaneous Nerve Field Stimulator (PNFS) supports the reduction of opioid …See details»